Continuing Medical Education: Online CME: Rheumatology CME: Update in the Diagnosis and Management of Seronegative Spondyloarthropathies: National Association of Continuing Education (NACE): Oct. 12, 2009 - Oct. 11, 2011
http://www.cmenetworks.com/cme/11582/1/Continuing-Medical-Education-Online-CME-Rheumatology-CME-Update-in-the-Diagnosis-and-Management-of-Seronegative-Spondyloarthropathies-National-Association-of-Continuing-Education-NACE-Oct-12-2009---Oct-11-2011/Page1.html
National Association for Continuing Education (NACE)
The mission of the National Association for Continuing Education (NACE) is to offer continuing education opportunities to provide learners in the fields of medicine, behavioral health, education, and related disciplines, with the most up-to-date, science-based information that will enable them to maintain or increase their knowledge, skills, and professional performance to ultimately benefit the public’s health.
By National Association for Continuing Education (NACE)
Published on 05/27/2010
Update in the Diagnosis and Management of Seronegative Spondyloarthropathies
National Association of Continuing Education (NACE)
Oct. 12, 2009 - Oct. 11, 2011
CME Sponsor:
National Association of Continuing Education (NACE)
Location:
Online
Course Directors:
(Disclosures Included)
Alan Brown, MD,
Course Director
Abbott, Takeda Consultant - UCB
Jefrey Lieberman, MD FACP
Course Director
Consulting/Speaking/Teaching
Pfizer, Sanofi Synthlabo, Forest, Abbott, Roche, Novartis
Harvey Parker, PhD,
Activity Planning Committee
has no relationships to disclose
Michelle Frisch, MPH
Activity Planning Committeehas no relationships to disclose.
Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
Number of Credits:
1 AMA PRA Category 1 Credits™
Registration Fee:
Free
More Info
Detailed Description:
Welcome to the National Association for Continuing Education webcast of our New Perspectives in the Management of Rheumatic Diseases: Update 2009. The topic of this webcast is Update in the Diagnosis and Management of Seronegative Spondyloarthropathies.
The program was captured live in Hallandale, Florida on September 26, 2009 and features Dr. Alan Brown. Dr. Brown is Associate Professor of Medicine in the Division of Rheumatology and Immunology within the Department of Medicine at the Medical University of South Carolina in Charleston, South Carolina.
Update in the Diagnosis and Management of Seronegative Spondyloarthropathies
National Association of Continuing Education (NACE)
Oct. 12, 2009 - Oct. 11, 2011
Update in the Diagnosis and Management of Seronegative Spondyloarthropathies
CME Sponsor:
National Association of Continuing Education (NACE)
Location:
Online
Course Directors:
(Disclosures Included)
Alan Brown, MD,
Course Director
Abbott, Takeda Consultant - UCB
Jefrey Lieberman, MD FACP
Course Director
Consulting/Speaking/Teaching
Pfizer, Sanofi Synthlabo, Forest, Abbott, Roche, Novartis
Harvey Parker, PhD,
Activity Planning Committee
has no relationships to disclose
Michelle Frisch, MPH
Activity Planning Committeehas no relationships to disclose.
Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
Number of Credits:
1 AMA PRA Category 1 Credits™
Registration Fee:
Free
More Info
Detailed Description:
Welcome to the National Association for Continuing Education webcast of our New Perspectives in the Management of Rheumatic Diseases: Update 2009. The topic of this webcast is Update in the Diagnosis and Management of Seronegative Spondyloarthropathies.
The program was captured live in Hallandale, Florida on September 26, 2009 and features Dr. Alan Brown. Dr. Brown is Associate Professor of Medicine in the Division of Rheumatology and Immunology within the Department of Medicine at the Medical University of South Carolina in Charleston, South Carolina.
Learning Objectives:
After completing this program participants should be able to:
- discuss the pathogenesis of PsA and AS
- recognize symptoms of PsA and AS and procedures used to appropriately diagnose these diseases
- discuss the latest advancements in the treatment of PsA and AS